Brentwood, Tenn.-based Surgery Partners has revised its full-year 2025 guidance downward to $3.275 billion to $3.3 billion in revenue and $535 million to $540 million in adjusted EBITDA, CEO Eric Evans said in an earnings call transcribed by The Motley Fool. Year-to-date, Surgery Partners has deployed $71 million toward acquisitions and completed three ASC divestitures, generating $45 million in cash and reducing debt by $5 million, according to Mr. Evans. The company is pursuing “divestitures or partnerships for non-core hospital assets” with higher capital intensity — a move designed to reduce leverage and boost cash flow, Mr. Evans said.
Read the full article: Why Surgery Partners Is Scaling Back Its 2025 Revenue Forecast //
Source: https://www.beckersasc.com/asc-transactions-and-valuation-issues/why-surgery-partners-is-scaling-back-its-2025-revenue-forecast/